Key Takeaways
- SPCX shares declined 4.05% on Thursday, retreating below the $135 IPO level
- A total of 319 million previously restricted shares entered the tradable float
- Thursday’s pullback broke a six-session run of closes above the IPO price
- The $60 billion Cursor acquisition, finalized August 14, introduced approximately 389 million additional Class A shares through an all-stock transaction
- Wall Street analysts hold a Moderate Buy view with a consensus target of $232.35
Shares of SpaceX tumbled 4.05% during Thursday’s trading session, slipping back beneath the company’s $135 IPO price point to settle in the $130-$134 range. The downturn coincided with the expiration of restrictions on 319 million shares.
Space Exploration Technologies Corp., SPCX
Thursday marked the second time a major lockup restriction has lifted since the aerospace company’s June public debut. These newly available shares account for approximately 7% of SpaceX’s entire share count.
The selloff snapped a six-trading-day period during which SPCX managed to hold above its debut price. Thursday also represented the third straight session of losses for the stock.
Back on August 6, the first lockup period concluded, releasing 911.5 million shares and effectively doubling SpaceX’s available float. Notably, shares climbed 6% during that initial, much larger unlock event. Thursday’s comparatively modest release produced the inverse reaction.
The contrasting market response appears rooted in shifting demand dynamics and mounting dilution anxieties. With the float having already ballooned substantially, buying interest at prevailing valuations proved insufficient to absorb the new supply.
Cursor Acquisition Compounds Share Dilution
Thursday’s unlock occurred mere days following the August 14 completion of SpaceX’s $60 billion acquisition of Cursor, an AI-powered coding assistant platform. The entirely stock-based transaction generated around 389 million fresh Class A shares, intensifying dilution concerns.
Between the acquisition-related issuance and the lockup expiration, SPCX’s tradable share base has expanded considerably within a compressed timeframe.
SpaceX has encountered additional headwinds from its aggressive capital deployment strategy. The company’s second-quarter financial results revealed $18.4 billion in capital expenditures, unsettling market participants and triggering an approximate 8% stock decline upon disclosure.
Prior to that, a $25 billion corporate debt issuance in late June sparked a sharp 16% single-session plunge as investors questioned the company’s cash consumption rate.
Additional Share Unlocks Scheduled Through 2027
The lockup release calendar contains several more significant dates. November 2026 will see another 1.3 billion shares become tradable, coinciding with the company’s third-quarter earnings announcement. The complete 180-day IPO lockup restriction lifts in December 2026.
The most substantial supply event arrives in June 2027, when Elon Musk’s 6.42 billion share position becomes eligible for sale. This final unlock dwarfs all preceding releases in magnitude.
SpaceX executed the largest initial public offering in American corporate history on June 12, debuting at $135 per share. The stock experienced a powerful initial rally, reaching an all-time peak of $225.64 and temporarily propelling SpaceX’s market capitalization above tech giants Microsoft and Amazon.
Since that early euphoria, shares have retreated to the $130-$140 corridor, including a post-IPO trough of $108.27 registered less than eight weeks following the listing.
Notwithstanding the pronounced price swings, the analyst community maintains a constructive stance. SPCX holds a Moderate Buy consensus rating derived from 24 Buy recommendations, five Hold ratings, and three Sell calls among analysts covering the stock since its public market debut.
The mean analyst price objective stands at $232.35, suggesting potential appreciation of approximately 73% from current trading levels.



